*** Proof of Product ***
Exploring the Essential Features of “Steven Atkinson – Dementia Medication Update”
Dementia Medication Update
Speaker: Steven Atkinson, PA-C, MS
Duration: 2 Hours 02 Minutes
Format: Audio and Video
Description
Dementia of any type is a chronic disease with progressive deterioration of cognition, function, and behavior. The prevalence is only expected to increase as the patient population ages. This will result in a considerable challenge to patients, families, caregivers and facilities. Knowing the pharmacological DO’s and DON’TS for those with dementia can change outcomes, but understanding what not to prescribe can be difficult. In this session, hear a Geriatrician’s approach to the newest diagnostics and treatments in dementia, screening for the pharmacological deliriants that contribute to dementia, and placing emphasis on deprescribing unnecessary medications.
Speaker
Steven Atkinson, PA-C, MS
Steven Atkinson, PA-C, MS, is a board-certified Physician Assistant specializing in Geriatric Internal Medicine. He practices medicine in the greater Minneapolis area. In addition to his private practice, he has been on the faculty at the University of Utah since 1994 and has been involved in medicine for over 30 years.
Steven is the co-founder of Twin Cities Physicians, which serves older adults at nearly all levels of their care. He has presented nationally for over 15 years, primarily speaking about geriatric-related syndromes.
Steven is the author of Geriatric Pharmacology: The Principals of Practice & Clinical Recommendations, Second Edition, and also sits on several boards whose purpose is to elevate the level of care in medicine for the patients they serve. Steven has been described as a “dynamic” educator and one of the most engaging presenters around.
Speaker Disclosures:
Financial: Steven Atkinson is the founder and co-owner of Twin Cities Physicians and Midwest Geriatrics Services, and he is the owner of Mindful Geriatrics, LLC. He provides legal counseling services to medical professionals and receives compensation. Mr. Atkinson receives a fee for course development from Executive Links. He is adjunct faculty at the University of Utah. Mr. Atkinson receives a speaking honorarium and recording royalties from PESI, Inc. He owns stocks/shares in Moderna, Inc and was a previous stock/shares owner in Lilly. He has no relevant financial relationships with ineligible organizations.
Non-financial: Steven Atkinson is a member of the board for MDMA. He is a member of AMDA/PALTC, GMPA, and others.
Objectives
- Evaluate drug choices based on dementia type.
- Determine tools to help in diagnosing common dementia types.
- Analyze common pharmacological deliriants.
- Determine the value of deprescribing in dementia care.
Outline
Delirium
- The current algorithm of delirium
- A simpler approach to delirium
The Importance of Screening for Depression
How Medications Can Confound the Picture
The Anticholinergic Burden Score
The Importance of Cognitive Screens
- A screening test for all settings
Alzheimer’s Disease
- The general hypothesis
- The value of screening
- The NEWEST biological definition of SDAT
- LATE-NC – newly defined form of dementia
Target Audience
• Nurses • Nurse Practitioners • Clinical Nurse Specialists • Physicians • Physician Assistants
Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/
